Nebraska Cancer Specialists Midwest Cancer Center

Omaha, Nebraska 68130

1 studies enrolling now · 1 studies all time

What they study most

Colorectal Neoplasms

Studies at this site

• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now